Sign Out
Initial treatment of advanced ovarian carcinoma of epithelial origin in established combinations with other approved chemotherapeutic agents.
For the palliative treatment of ovarian carcinoma of epithelial origin refractory to standard chemotherapy with or without cisplatin.
For the treatment of small cell lung carcinoma (SCLC).
Continue with Google